Filter Type: All Time (8 Results) Past 24 Hours Past Week Past month Post Your Comments?
Thomas J. Schall, Ph.D. President and Chief Executive Officer . ChemoCentryx, Inc. 850 Maude Avenue Mountain View, CA 94043 (650) 210-2900 (Address, including zip code, and telephone number, including area code, of agent for service) C
Preview / Show more
Updated: just now
See Also: Verify It Show details
SAN CARLOS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences: Stifel 2021 Virtual Healthcare Conference Fireside Chat Wednesday, November 17 at 2:00 p.m. Eastern Time; Piper Sandler 33rd Annual …
Preview / Show more
Updated: 4 hours ago
See Also: Show details
ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript Nov. 10, 2021 at 1:01 a.m. ET on Motley Fool ChemoCentryx (CCXI) Reports Q3 Loss, Tops Revenue Estimates
Preview / Show more
Updated: 1 hours ago
See Also:Vintage Stock Phone Number, Robinhood Stock Phone Number, Show details
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Preview / Show more
Updated: 5 hours ago
See Also:Vintage Stock Phone Number, Robinhood Stock Phone Number, Show details
ChemoCentryx, Inc is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact.
Preview / Show more
Updated: 1 hours ago
See Also: Show details
Using a suite of innovative personality-based products, Mattersight can analyze and predict customer behavior based on the language exchanged during service and sales interactions. This insight can then facilitate real-time connections between customers and the agents best capable of handling their needs.
Preview / Show more
Updated: 2 hours ago
See Also:Capital One Venture Phone Number, Capital Newspapers Contact, Show details
ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan. The payment it earned for that milestone from its partner Vifor for $20 ...
Preview / Show more
Updated: 5 hours ago
See Also:Motley Fool Phone Numbers, Motley Fool Canada Phone Number, Show details
ChemoCentryx Inc (NASDAQ:CCXI) is the most popular stock in this table. On the other hand Humacyte Inc. (NASDAQ: HUMA ) is the least popular one with only 5 …
Preview / Show more
Updated: 3 hours ago
See Also:Hcc Phone Number, Hcc Fax Number, Show details
All Time (8 Results)
Past 24 Hours
Past Week
Past month
MOUNTAIN VIEW, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for avacopan for the treatment of patients with ANCA-associated vasculitis.
ChemoCentryx Inc. (CCXI) reports a wider-than-expected loss in the second quarter and misses on sales. Joining us on the call today is Dr. Thomas Schall, President and Chief Executive Officer of ChemoCentryx, who will review the Company’s recent business and clinical progress.
Investors need to pay close attention to ChemoCentryx (CCXI) stock based on the movements in the options market lately. The latest analyst coverage could presage a bad day for ChemoCentryx, Inc. ( NASDAQ:CCXI ), with the analysts making...
MOUNTAIN VIEW, Calif. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. , (Nasdaq: CCXI), today announced that the Company’s second quarter 2021 financial results will be released after market close on Monday, August 9, 2021 . ChemoCentryx executive management will host a conference call and